Pacific Biosciences of California, Inc. Other Cost of Operating Revenue
Pacific Biosciences of California, Inc. (PACB) reported Other Cost of Operating Revenue of $3.01 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherCostOfOperatingRevenue · last filed 2022-11-08
- Pacific Biosciences of California, Inc. other cost of operating revenue for the quarter ending 2022-09-30 was $3.01M, a 22.17% decline year-over-year.
- Pacific Biosciences of California, Inc. other cost of operating revenue for the quarter ending 2022-06-30 was $3.59M, a 1.18% decline year-over-year.
- Pacific Biosciences of California, Inc. other cost of operating revenue for the quarter ending 2022-03-31 was $4.01M, a 20.82% increase year-over-year.
- Pacific Biosciences of California, Inc. other cost of operating revenue for the quarter ending 2021-09-30 was $3.87M.
- Pacific Biosciences of California, Inc. other cost of operating revenue for fiscal 2017 was $15.91M, a 32.11% increase from fiscal 2016.
- Pacific Biosciences of California, Inc. other cost of operating revenue for fiscal 2016 was $12.04M, a 39.57% increase from fiscal 2015.
- Pacific Biosciences of California, Inc. other cost of operating revenue for fiscal 2015 was $8.63M, a 14.04% increase from fiscal 2014.
- Pacific Biosciences of California, Inc. other cost of operating revenue for fiscal 2014 was $7.57M, a 24.93% increase from fiscal 2013.
| Period end | Other Cost of Operating Revenue 3 month | Other Cost of Operating Revenue 6 month | Other Cost of Operating Revenue 9 month | Other Cost of Operating Revenue 12 month |
|---|---|---|---|---|
| 2022-09-30 | $3.01M 10-Q · filed 2022-11-08 | $6.60M derived: sum of 2 quarters · filed 2022-11-08 | $10.62M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $3.59M 10-Q · filed 2022-08-08 | $7.61M 10-Q · filed 2022-08-08 | ||
| 2022-03-31 | $4.01M 10-Q · filed 2022-05-06 | |||
| 2021-09-30 | $3.87M 10-Q · filed 2022-11-08 | $7.50M derived: sum of 2 quarters · filed 2022-11-08 | $10.83M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $3.63M 10-Q · filed 2022-08-08 | $6.96M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $3.32M 10-Q · filed 2022-05-06 | |||
| 2018-03-31 | $3.05M 10-Q · filed 2018-05-02 | $6.65M derived: sum of 2 quarters · filed 2018-05-02 | $10.42M derived: sum of 3 quarters · filed 2018-05-02 | $14.34M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $7.38M derived: sum of 2 quarters · filed 2018-02-26 | $11.29M derived: sum of 3 quarters · filed 2018-02-26 | $15.91M 10-K · filed 2018-02-26 |
| 2017-09-30 | $3.77M 10-Q · filed 2017-11-02 | $7.69M derived: sum of 2 quarters · filed 2017-11-02 | $12.30M 10-Q · filed 2017-11-02 | $15.41M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-06-30 | $3.92M 10-Q · filed 2017-08-02 | $8.53M 10-Q · filed 2017-08-02 | $11.64M derived: sum of 3 quarters · filed 2018-05-02 | $14.84M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-03-31 | $4.62M 10-Q · filed 2018-05-02 | $7.72M derived: sum of 2 quarters · filed 2018-05-02 | $10.93M derived: sum of 3 quarters · filed 2018-05-02 | $13.91M derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $6.31M derived: sum of 2 quarters · filed 2018-02-26 | $9.30M derived: sum of 3 quarters · filed 2018-02-26 | $12.04M 10-K · filed 2018-02-26 |
| 2016-09-30 | $3.21M 10-Q · filed 2017-11-02 | $6.20M derived: sum of 2 quarters · filed 2017-11-02 | $8.94M 10-Q · filed 2017-11-02 | $11.34M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $2.99M 10-Q · filed 2017-08-02 | $5.73M 10-Q · filed 2017-08-02 | $8.13M derived: sum of 3 quarters · filed 2018-02-26 | $10.38M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $2.74M 10-Q · filed 2017-05-05 | $5.14M derived: sum of 2 quarters · filed 2018-02-26 | $7.39M derived: sum of 3 quarters · filed 2018-02-26 | $9.38M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $4.65M derived: sum of 2 quarters · filed 2018-02-26 | $6.64M derived: sum of 3 quarters · filed 2018-02-26 | $8.63M 10-K · filed 2018-02-26 |
| 2015-09-30 | $2.25M 10-Q · filed 2016-11-04 | $4.24M derived: sum of 2 quarters · filed 2016-11-04 | $6.23M 10-Q · filed 2016-11-04 | $8.12M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $2.00M 10-Q · filed 2016-08-04 | $3.98M 10-Q · filed 2016-08-04 | $5.87M derived: sum of 3 quarters · filed 2017-03-06 | $7.72M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $1.99M 10-Q · filed 2016-05-05 | $3.87M derived: sum of 2 quarters · filed 2017-03-06 | $5.73M derived: sum of 3 quarters · filed 2017-03-06 | $7.75M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $3.74M derived: sum of 2 quarters · filed 2017-03-06 | $5.77M derived: sum of 3 quarters · filed 2017-03-06 | $7.57M 10-K · filed 2017-03-06 |
| 2014-09-30 | $1.85M 10-Q · filed 2015-11-05 | $3.88M derived: sum of 2 quarters · filed 2015-11-05 | $5.68M 10-Q · filed 2015-11-05 | $7.05M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $2.03M 10-Q · filed 2015-08-05 | $3.83M 10-Q · filed 2015-08-05 | $5.20M derived: sum of 3 quarters · filed 2016-03-11 | $6.76M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $1.80M 10-Q · filed 2015-05-05 | $3.17M derived: sum of 2 quarters · filed 2016-03-11 | $4.74M derived: sum of 3 quarters · filed 2016-03-11 | $6.40M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $2.94M derived: sum of 2 quarters · filed 2016-03-11 | $4.61M derived: sum of 3 quarters · filed 2016-03-11 | $6.06M 10-K · filed 2016-03-11 |
| 2013-09-30 | $1.56M 10-Q · filed 2014-11-05 | $3.23M derived: sum of 2 quarters · filed 2014-11-05 | $4.68M 10-Q · filed 2014-11-05 | $6.08M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $1.67M 10-Q · filed 2014-08-05 | $3.12M 10-Q · filed 2014-08-05 | $4.52M derived: sum of 3 quarters · filed 2015-03-12 | $6.14M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $1.45M 10-Q · filed 2014-05-08 | $2.85M derived: sum of 2 quarters · filed 2015-03-12 | $4.48M derived: sum of 3 quarters · filed 2015-03-12 | $6.11M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $3.03M derived: sum of 2 quarters · filed 2015-03-12 | $4.66M derived: sum of 3 quarters · filed 2015-03-12 | $6.25M 10-K · filed 2015-03-12 |
| 2012-09-30 | $1.63M 10-Q · filed 2013-11-12 | $3.26M derived: sum of 2 quarters · filed 2013-11-12 | $4.84M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $1.63M 10-Q · filed 2013-08-09 | $3.22M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $1.58M 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | $2.10M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |